217 related articles for article (PubMed ID: 25754568)
1. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
[TBL] [Abstract][Full Text] [Related]
2. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
[TBL] [Abstract][Full Text] [Related]
3. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
4. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
[TBL] [Abstract][Full Text] [Related]
5. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
[TBL] [Abstract][Full Text] [Related]
6. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
[TBL] [Abstract][Full Text] [Related]
7. Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence.
Engelman D; Ah Kee M; Mataika RL; Kado JH; Colquhoun SM; Tulloch J; Steer AC
Trans R Soc Trop Med Hyg; 2017 Apr; 111(4):154-162. PubMed ID: 28673022
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
[TBL] [Abstract][Full Text] [Related]
9. Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.
Barker H; Oetzel JG; Scott N; Morley M; Carr PEA; Oetzel KB
Int J Equity Health; 2017 Nov; 16(1):201. PubMed ID: 29149897
[TBL] [Abstract][Full Text] [Related]
10. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.
Arvind B; Saxena A; Kazi DS; Bolger AF
Indian Heart J; 2021; 73(2):169-173. PubMed ID: 33865513
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
Rémond MG; Coyle ME; Mills JE; Maguire GP
Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
[TBL] [Abstract][Full Text] [Related]
12. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
Okello E; Longenecker CT; Beaton A; Kamya MR; Lwabi P
BMC Cardiovasc Disord; 2017 Jan; 17(1):20. PubMed ID: 28061759
[TBL] [Abstract][Full Text] [Related]
13. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India.
Kumar R; Thakur JS; Aggarwal A; Ganguly NK
Indian Heart J; 1997; 49(3):282-8. PubMed ID: 9291651
[TBL] [Abstract][Full Text] [Related]
14. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
[TBL] [Abstract][Full Text] [Related]
15. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
[TBL] [Abstract][Full Text] [Related]
16. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
[TBL] [Abstract][Full Text] [Related]
17. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
[TBL] [Abstract][Full Text] [Related]
18. Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis.
Jaiteh LES; Drammeh L; Anderson ST; Mendy J; Ceesay S; D'Alessandro U; Carapetis J; Mirabel M; Erhart A
BMC Cardiovasc Disord; 2021 Oct; 21(1):503. PubMed ID: 34663206
[TBL] [Abstract][Full Text] [Related]
19. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
Liaw J; Gorton S; Heal C; White A
Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
[TBL] [Abstract][Full Text] [Related]
20. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.
Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC
Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
